West Pharmaceutical Services (NYSE:WST) yesterday said it launched two new elastomer products, the 4040/40 formulation elastomer and an extension of its AccelTRA component program.
The 4040/40 formulation was created using customer insights to improve performance and reliability. It comes in two stopper designs in 13mm and 20mm sizes with a universal design to deliver high functionality and reliability, according to the company.
West’s AccelTRA components include AccelTRA 13mm and 20mm serum and lyo stoppers in multiple configurations with a 1-3mL uncoated plunger.
“These new elastomer product offerings reflect West’s deep commitment to innovation based on customer insights. Designed with the customers’ challenges in mind, we aim to simplify their journey with drug packaging and delivery solutions and help bring much-needed injectable medicines to patients more quickly and efficiently,” SVP and chief commercial officer Karen Flynn said in a news release. “CPhl also marks our first full year offering the Integrated Solutions program, our comprehensive approach to working by our customers’ side to help reduce risk and regulatory complexity. Together with these new product offerings, West supports customers as they navigate the journey from early development to commercialization.”
